Teva- Pharmaceutical Industries Ltd. ADR (TEVA)

Precedente Chiudi:

$13.98

Aprire:

$13.92

Volume 24 ore:

9.13M

Capitalizzazione di mercato:

$15.92B

Reddito:

$15.85B

Utile/perdita netta:

$-559.00M

Rapporto P/E:

-7.03

EPS:

-2

Flusso di cassa netto:

$842.00M

1 W Prestazione:

-0.28%

1M Prestazione:

-1.33%

6M Prestazione:

+55.36%

1 anno Prestazione:

+60.32%

Intervallo 1D:

$13.88

$14.11

Portata 52W:

$7.085

$14.46

Teva- Pharmaceutical Industries Ltd. ADR Stock (TEVA) Company Profile

Nome

Teva- Pharmaceutical Industries Ltd. ADR

Settore

Healthcare (1215)

Industria

Drug Manufacturers - Specialty & Generic (3)

Telefono

972 3 914 8171

Indirizzo

5 Basel Street, Petach Tikva

Dipendente

51,792

Cinguettio

@TevaUSA

Prossima data di guadagno

2024-05-14

Ultimi documenti SEC

TEVA's Discussions on Twitter

Teva- Pharmaceutical Industries Ltd. ADR Stock (TEVA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-12	Aggiornamento	Piper Sandler	Neutral → Overweight
2024-01-23	Aggiornamento	Jefferies	Hold → Buy
2024-01-03	Aggiornamento	Piper Sandler	Underweight → Neutral
2023-12-18	Iniziato	HSBC Securities	Buy
2023-11-27	Aggiornamento	UBS	Neutral → Buy
2023-07-06	Aggiornamento	UBS	Sell → Neutral
2023-05-25	Iniziato	Morgan Stanley	Equal-Weight
2023-05-18	Aggiornamento	Evercore ISI	In-line → Outperform
2023-01-19	Downgrade	Jefferies	Buy → Hold
2022-11-14	Downgrade	JP Morgan	Neutral → Underweight
2022-11-04	Downgrade	UBS	Neutral → Sell
2022-10-21	Ripresa	Jefferies	Buy
2022-08-05	Aggiornamento	BofA Securities	Neutral → Buy
2022-06-14	Ripresa	UBS	Neutral
2022-05-17	Aggiornamento	BofA Securities	Underperform → Neutral
2022-05-04	Downgrade	Piper Sandler	Neutral → Underweight
2022-04-05	Aggiornamento	Barclays	Equal Weight → Overweight
2022-03-25	Aggiornamento	Bernstein	Mkt Perform → Outperform
2022-01-27	Downgrade	Argus	Buy → Hold
2021-10-28	Downgrade	Raymond James	Outperform → Mkt Perform
2021-05-04	Downgrade	UBS	Buy → Neutral
2021-04-07	Ripresa	RBC Capital Mkts	Sector Perform
2020-11-25	Iniziato	Oppenheimer	Perform
2020-08-06	Aggiornamento	Barclays	Underweight → Equal Weight
2020-07-27	Ripresa	Goldman	Neutral
2020-06-01	Aggiornamento	SunTrust	Hold → Buy
2020-04-24	Ripresa	Citigroup	Neutral
2020-04-06	Aggiornamento	UBS	Neutral → Buy
2020-02-24	Downgrade	Edward Jones	Hold → Sell
2019-11-12	Aggiornamento	JP Morgan	Underweight → Neutral
2019-10-17	Aggiornamento	Gabelli & Co	Hold → Buy
2019-08-07	Downgrade	Evercore ISI	Outperform → In-line
2019-07-19	Iniziato	Wolfe Research	Peer Perform
2019-07-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2019-07-10	Ripresa	Credit Suisse	Neutral
2019-07-05	Aggiornamento	Argus	Hold → Buy
2019-06-11	Iniziato	Barclays	Underweight
2019-06-03	Aggiornamento	Oppenheimer	Perform → Outperform
2019-05-30	Downgrade	BofA/Merrill	Buy → Underperform
2019-05-28	Downgrade	UBS	Buy → Neutral
2019-03-20	Iniziato	SunTrust	Hold
2019-03-07	Ripresa	UBS	Buy

Mostra tutto

Teva- Pharmaceutical Industries Ltd. ADR Borsa (TEVA) Ultime notizie

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Zacks Investment Research

Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics

Zacks Investment Research

Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris

Zacks Investment Research

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

Zacks Investment Research

Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead

The Motley Fool

3 No-Brainer Stocks to Buy With $600 Right Now

The Motley Fool

Teva- Pharmaceutical Industries Ltd. ADR Azioni (TEVA) Dati Finanziari

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Reddito 2024

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Reddito netto 2024

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Flusso di cassa 2024

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Utile per azione 2024

Teva- Pharmaceutical Industries Ltd. ADR Azioni (TEVA) insider trading